Clinical Trials Sponsored by Sundar Jagannath

Total 305 results

Jagannath, Sundar, M.D.
Unicorn Pacific Corporation

Terminated

Study of TBL 12 Sea Cucumber Extract for Patients With Untreated Asymptomatic Myeloma

Multiple Myeloma

United States
Sundar Jagannath
Bristol-Myers Squibb

No longer available

Expanded Access Single Named Patient Program With Elotuzumab (BMS-901608) for the Treatment of Patient R-A With Relapsed/Refractory Multiple Myeloma

Multiple Myeloma

United States
Jagannadha R Avasarala

Withdrawn

MS and NMOSD in African-Americans

Multiple Sclerosis | Neuromyelitis Optica

United States
Krishna M. Sundar

Completed

Sham CPAP vs. Straight CPAP for Chronic Cough

OSA | Chronic Cough

United States
Jagannadha R Avasarala

Terminated

Diagnosis of ON With or Without MS or NMOSD

Multiple Sclerosis | Optic Neuritis | Neuromyelitis Optica Spectrum Disorder Attack | Neuromyelitis Optica Spectrum Disorder Relapse | Neuromyelitis Optica Spectrum Disorder Progression

United States
Syndax Pharmaceuticals

Terminated

A Phase I, Multicenter, Open Label Study on the Effects of SNDX-275 on Expression of Biomarkers in Subjects With Newly Diagnosed Breast Cancer

Breast Cancer

United States
Sunstar Americas

Completed

Evaluation of Toothbrush Bristles in Plaque Reduction

Gingivitis | Plaque, Dental

United States
Sunstar Americas

Terminated

Efficacy of Synthetic Bone Graft for Treatment of Peri-implantitis

Peri-Implantitis

United States
Sunstar Americas

Completed

Case Series of New Alloplastic Bone Graft Material

Oral Surgery | Periodontology

United States
Emine Dundar Ahi

Completed

Dry Needling and High Intensity Laser Therapy in Treatment of Myofascial Pain Syndrome

Myofascial Pain Syndrome

Turkey
Syndax Pharmaceuticals

Recruiting

Study of Radiolabeled Revumenib in Adults With Acute Leukemia

Acute Leukemia

United States
Sunway University

Not yet recruiting

Reducing Vaccine Hesitancy (VH) And Vaccine Refusal (VR): Its' Correlation Factors and an Educational Intervention Programme

COVID-19 Vaccination

Malaysia
Syndax Pharmaceuticals

Available

Expanded Access Program for Revumenib

Relapsed/Refractory Acute Leukemia

United States
Syndax Pharmaceuticals

Active, not recruiting

A Study of Axatilimab at 3 Different Doses in Participants With Chronic Graft Versus Host Disease (cGVHD) (AGAVE-201)

Chronic Graft-versus-host-disease

Korea, Republic of, United States, Spain, Taiwan, France, Singapore, Belgium, Germany, Italy, Canada, Israel, Australia, United Kingdom, Greece, Poland, Portugal
Syndax Pharmaceuticals

Active, not recruiting

A Phase 1/2 Study to Evaluate SNDX- 6352 in Participants With Active cGVHD

Chronic Graft-versus-host-disease

United States
Syndax Pharmaceuticals

Completed

Study to Evaluate Erlotinib With or Without SNDX-275 (Entinostat) in the Treatment of Patients With Advanced NSCLC

Carcinoma, Non-Small Cell Lung | Non-Small-Cell Lung Carcinoma

United States
Syndax Pharmaceuticals

Terminated

A Phase 2 Study to Evaluate Axatilimab for Hospitalized Participants With Respiratory Involvement Secondary to COVID-19

COVID | ARDS | Coronavirus | Cytokine Storm | Cytokine Release Syndrome

United States
Sunstar Americas

Terminated

Ridge Preservation With Moldable Beta-tricalcium Phosphate Bone Substitute on Non-containable Non-Molar Extraction Sites

Dental Implants | Alveolar Ridge Preservation

United States
Syndax Pharmaceuticals

Terminated

A Phase 2 Multi-Center Study of Entinostat (SNDX-275) in Patient With Relapsed or Refractory Hodgkin's Lymphoma (ENGAGE-501)

Hodgkin's Lymphoma

United States
Syndax Pharmaceuticals

Completed

A Study to Examine the Effect of Omeprazole, Famotidine, and an Acidic Beverage on the Pharmacokinetics of Entinostat in Healthy Adult Subjects

Healthy Volunteers | Volunteers | Normal Volunteers | Human Volunteers

United States
Syndax Pharmaceuticals

Completed

A Study to Examine the Effects of Entinostat on Midazolam in Healthy Adult Subjects

Healthy Volunteer | Drug Interaction

United States
Sunstar Americas

Completed

A Clinical Trial to Evaluate Long-term Efficacy and Safety of Lozenges Containing Lactobacilli Reuteri (Prodentis™) on Gingivitis

Gingivitis

United States
Sunway University

Completed

Ginseng and Ginkgo Biloba Effects on Cognition as Modulated by Cardiovascular Reactivity

Blood Pressure | Cognition

Malaysia
Syndax Pharmaceuticals

Withdrawn

Phase 2 Study of Fulvestrant With and Without Entinostat in Postmenopausal Women With ER+ Advanced Breast Cancer (ENCORE305)

Breast Cancer

United States
Sunstar Americas

Completed

Periocline as an Adjunct to Scaling and Root Planing for Adult Periodontitis

Adult Periodontitis

United States
Sunway University

Recruiting

Successful Aging and Age-related Decline (MyAgeWell)

Aging | Elderly | Cognitive Decline | Intervention Study | Physical Decline

Malaysia
Syndax Pharmaceuticals

Recruiting

A Study of SNDX-5613 in Combination With Intensive Chemotherapy in Participants With Acute Myeloid Leukemias

Acute Myeloid Leukemias

United States
Syndax Pharmaceuticals

Recruiting

Evaluation of Revumenib in Participants With Colorectal Cancer and Other Solid Tumors

Colorectal Cancer | Solid Tumors

United States
Syndax Pharmaceuticals

Recruiting

A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation (AUGMENT-101)

Acute Myeloid Leukemia | Acute Lymphoblastic Leukemia | Acute Leukemia of Ambiguous Lineage | Mixed Phenotype Acute Leukemia | Mixed Lineage Acute Leukemia

United States, Israel, Spain, Australia, Netherlands, Germany, Canada, France, Italy, Lithuania
Syndax Pharmaceuticals

Completed

A Phase 1 Study to Investigate Axatilimab Alone or in Combination With Durvalumab in Patients With Solid Tumors

Solid Tumor | Unresectable Malignant Neoplasm | Locally Advanced Malignant Neoplasm | Metastatic Tumor

United States
Syndax Pharmaceuticals

Active, not recruiting

A Study of Revumenib in Combination With Chemotherapy in Participants With R/R Acute Leukemia

Acute Myeloid Leukemia | Acute Lymphoblastic Leukemia | Acute Lymphocytic Leukemia | Acute Undifferentiated Leukemia | Relapsed/Refractory Leukemias | Mixed Phenotype Acute Leukemia

United States, Canada
Syndax Pharmaceuticals

Terminated

A Phase 2 Exploratory Study of Erlotinib and SNDX-275 in Participants With Non-small Cell Lung Carcinoma Who Are Progressing on Erlotinib

Non Small Cell Lung Cancer

United States
Syndax Pharmaceuticals

Completed

Study of the Effect of the Addition of SNDX-275 (Entinostat) to Continued Aromatase Inhibitor (AI) Therapy in Postmenopausal Women With ER+ Breast Cancer Whose Disease is Progressing

ER+ Breast Cancer

Ireland, United Kingdom
Syndax Pharmaceuticals

Completed

Study to Evaluate Exemestane With and Without Entinostat (SNDX-275) in Treatment of Postmenopausal Women With Advanced Breast Cancer (ENCORE301)

Breast Cancer | ER+ Breast Cancer | Estrogen Receptor-Positive Breast Cancer | Breast Cancer, Estrogen Receptor-Positive

United States, Czechia, Canada, Hungary, Russian Federation
Syndax Pharmaceuticals

Completed

Cardiac Safety Study of Entinostat in Men and Women With Advanced Solid Tumors

Neoplasms | Neoplasms by Histologic Type | Lung Diseases | Neoplasms, Glandular and Epithelial | Digestive System Neoplasms | Endocrine Gland Neoplasms | Breast Neoplasms | Breast Diseases | Carcinoma, Non-Small-Cell Lung | Lung Neoplasms | Respiratory Tract Neoplasms | Thoracic Neoplasms | Bronchial Neoplasms | Solid... and other conditions

United States
Sunstar Americas

Completed

Clinical Evaluation of Oral Rinse for Xerostomia

Xerostomia

United States
Syndax Pharmaceuticals

Completed

Drug-Drug Interaction Study of Entinostat and Exemestane in Postmenopausal Women With ER+ Breast Cancer

Breast Cancer | Estrogen Receptor Positive Breast Cancer

United States
Syndax Pharmaceuticals

Completed

Study to Assess Food Effect on Pharmacokinetics of Entinostat in Subjects With Breast Cancer or Non-Small Cell Lung Cancer (ENCORE110)

Breast Cancer | Lung Cancer | Non Small Cell Lung Cancer (NSCLC) | Estrogen Receptor Breast Cancer

United States
Sunstar Americas

Completed

Assessment of Ridge Preservation Using Moldable Beta-tricalcium Phosphate Bone Grafting System

Dental Implants | Alveolar Ridge Preservation

United States
Sunstar Americas

Completed

GUIDOR® Growth Factor Enhanced Bone Graft Substitute for the Treatment of Periodontal Defects 6-months Post-Surgery

Periodontal Diseases | Alveolar Bone Loss

United States
Sunstar Americas

Completed

Curved Soft-Picks on Plaque Accumulation on Patients With Gingivitis

Gingivitis

United States
Syndax Pharmaceuticals

Completed

Study to Determine the Effect of the Timing of a Meal on the Pharmacokinetics of Entinostat

Healthy Volunteers | Volunteers | Normal Volunteers | Human Volunteers

United States
Syndax Pharmaceuticals

Completed

A Study to Evaluate the Pharmacokinetics of Entinostat in Adult Subjects With Normal and Impaired Renal Function

Renal Impairment | Healthy Volunteer

United States
Emine Dundar Ahi, MD

Completed

Effectiveness of Major Ozone Autohemotherapy in the Treatment of Fibromyalgia Syndrome

Fibromyalgia Syndrome

Turkey
Sundar Balasubramanian
National Cancer Institute (NCI); PranaScience Institute LLC

Completed

Breathwork App for Cancer Survivors

Breast Cancer

United States
Péterfy Sándor Hospital

Recruiting

Comparative Trial of Operative Treatment of Distal Pediatric Forearm Fractures With Biodegradable Nails and K-wires

Fracture Wrist

Hungary
Péterfy Sándor Hospital

Completed

A Central and Eastern European Survey On PEEP Titration and Alveolar Recruitment Manoeuvres During Surgery

Ventilator-Induced Lung Injury | Positive End-Expiratory Pressure | Alveolar Recruitment Manoeuvres

Hungary
University of Gondar

Recruiting

The Impact of Clinical Pharmacist Intervention on Asthmatic Patient's Outcomes

Asthma

Ethiopia
Seldar Pharma, Inc.

Completed

A Phase 2 Pilot Study to Assess ASP7147 in Patients With Diarrhea Predominant Irritable Bowel Syndrome (IBS-D)

Diarrhea Predominant Irritable Bowel Syndrome

United States
Sundara Reddy
Microdermis Corporation

Completed

ProvodineTM Decreases Hand Contamination

Hand Hygiene

United States

Clinical Trials Sponsored by Sundar Jagannath

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in United Arab Emirates

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations